{"schema_version":"secwatch.filing_event.v1","accession":"0001493152-26-029079","form_type":"8-K","ticker":"BFRI","cik":"0001858685","company_name":"Biofrontera Inc.","filed_at":"2026-06-17T20:05:19+00:00","discovered_at":"2026-06-17T20:06:00.266520+00:00","generated_at":"2026-06-17T20:07:00.092483+00:00","sec_items":["5.07"],"event_type":"other_material","sentiment":"neutral","materiality_score":0.6,"calibrated_materiality_score":0.15,"confidence":"high","headline":"Biofrontera shareholders elect directors and approve 5M share increase in incentive plan","bullets":["Elected Beth J. Hoffman and Kevin D. Weber as Class II directors until 2029; votes 8.09M and 8.20M for respectively.","Approved amendment to 2021 Omnibus Incentive Plan, increasing authorized shares from 3.75M to 8.75M; 7.89M for, 241K against.","Ratified CBIZ CPAs P.C. as independent auditor for FY2026; 10.9M for, 723K against.","Quorum of 11,630,133 votes present at June 11, 2026 Annual Meeting."],"urls":{"canonical":"https://secwatch.observer/filing/0001493152-26-029079","json":"https://secwatch.observer/filing/0001493152-26-029079.json","markdown":"https://secwatch.observer/filing/0001493152-26-029079.md","text":"https://secwatch.observer/filing/0001493152-26-029079.txt","edgar_index":"https://www.sec.gov/Archives/edgar/data/1858685/000149315226029079/0001493152-26-029079-index.htm","edgar_primary_document":"https://www.sec.gov/Archives/edgar/data/1858685/000149315226029079/form8-k.htm"},"model":{"generated_by":"deepseek-v4-flash:cloud@v2","generated_at":"2026-06-17T20:07:00.092483+00:00"},"review":{"review_status":"machine_generated","human_reviewed":false,"corrected":false,"correction_note":null,"correction_timestamp":null,"superseded_by":null,"related_filings":[]},"source_grounded_claims":[{"claim_id":"b317f638386fbec2ed183cda7903ccb28ed045ba","claim":"Biofrontera Inc. shareholders approved Approval of amendment and restatement of the Company's 2021 Omnibus Incentive Plan, including to increase the total number of shares of common stock authorized thereunder from 3,750,000 to 8,750,000. at the 2026-06-11 meeting.","evidence_excerpt":"Stockholders approved the amendment and restatement of the Company's 2021 Omnibus Incentive Plan, including to increase the total number of shares of common stock authorized thereunder from 3,750,000 to 8,750,000. The tabulation of votes cast was as follows: For Against Abstain Broker Non-Votes 7,893,236 241,359 175,881 3,319,657","evidence_source":"SEC 8-K Item 5.07","evidence_url":"https://www.sec.gov/Archives/edgar/data/1858685/000149315226029079/0001493152-26-029079-index.htm","confidence":0.9,"family_label":"Shareholder Votes","details":[{"label":"Proposal","value":"equity plan"},{"label":"Outcome","value":"passed"},{"label":"Meeting","value":"2026-06-11"}],"fact_type":"shareholder_vote"},{"claim_id":"d4ba44ead903dd0dd2342bdde7d8fd2d5f2ea48e","claim":"Biofrontera Inc. shareholders approved Ratification of appointment of CBIZ CPAs P.C. as the Company's independent registered public accounting firm for the fiscal year ending December 31, 2026. at the 2026-06-11 meeting.","evidence_excerpt":"Stockholders ratified the appointment of CBIZ CPAs P.C. as the Company's independent registered public accounting firm for the fiscal year ending December 31, 2026. The tabulation of votes cast was as follows: For Against Abstain Broker Non-Votes 10,905,016 723,806 1,311 0","evidence_source":"SEC 8-K Item 5.07","evidence_url":"https://www.sec.gov/Archives/edgar/data/1858685/000149315226029079/0001493152-26-029079-index.htm","confidence":0.9,"family_label":"Shareholder Votes","details":[{"label":"Proposal","value":"auditor ratification"},{"label":"Outcome","value":"passed"},{"label":"Meeting","value":"2026-06-11"}],"fact_type":"shareholder_vote"},{"claim_id":"fcded2ade2a837e9941ae7d4c177e12dc9e348eb","claim":"Biofrontera Inc. shareholders approved Stockholders elected Beth J. Hoffman, Ph.D. and Kevin D. Weber to serve as Class II directors of the Company until the 2029 Annual Meeting of Stockholders and until his or her successor has been duly elected and qualified, or until his or her earlier death, resignation, or removal. at the 2026-06-11 meeting.","evidence_excerpt":"Stockholders elected Beth J. Hoffman, Ph.D. and Kevin D. Weber to serve as Class II directors of the Company until the 2029 Annual Meeting of Stockholders and until his or her successor has been duly elected and qualified, or until his or her earlier death, resignation, or removal. The tabulation of votes cast was as follows: Beth J. Hoffman, Ph.D. For Withheld Broker Non-Votes 8,089,416 221,060 3,319,657 Kevin D. Weber For Withheld Broker Non-Votes 8,203,433 107,043 3,319,657","evidence_source":"SEC 8-K Item 5.07","evidence_url":"https://www.sec.gov/Archives/edgar/data/1858685/000149315226029079/0001493152-26-029079-index.htm","confidence":0.9,"family_label":"Shareholder Votes","details":[{"label":"Proposal","value":"director election"},{"label":"Outcome","value":"passed"},{"label":"Meeting","value":"2026-06-11"}],"fact_type":"shareholder_vote"}],"license":"Source filings: public domain (SEC EDGAR). Summaries (headline + bullets): CC-BY-4.0; attribute https://secwatch.observer"}